Navigation Links
Starving prostate cancer

Each year about 3300 Australian men die of prostate cancer. It's Australia's second worst cancer killer for men, matching the impact of breast cancer on women.

Current therapies for prostate cancer include surgical removal of the prostate, radiation, freezing the tumour or cutting off the supply of the hormone testosteronebut there are often side-effects including incontinence and impotence.

Growing cells need an essential nutrient, the amino acid called leucine, which is pumped into the cell by specialised proteins. And this could be prostate cancer's weak link.

Dr Jeff Holst and his team at the Centenary Institute found, in a study to be published this month in Cancer Research, that prostate cancer cells have more pumps than normal.

This allows the cancer cells to take in more leucine and outgrow normal cells.

"This information allows us to target the pumps and we've tried two routes. We found that we could disrupt the uptake of leucine firstly by reducing the amount of the protein pumps, and secondly by introducing a drug that competes with leucine. Both approaches slowed cancer growth, in essence 'starving' the cancer cells," Jeff says.

First author Dr Qian Wang says by targeting different sets of pumps, the researchers were able to slow tumour growth in both the early and late stages of prostate cancer.

"In some of the experiments, we were able to slow tumour growth by as much as 50 per cent. Our hope is that we could develop a treatment that slows the growth of the cancer so that it would not require surgical removal. If animal trials are successful over the next few years then clinical trials could start in as little as five years," he says.

Jeff says one of the other spin-offs of the discovery is a better understanding of the links between prostate cancer and eating foods high in leucine.

"Diets high in red meat and dairy are correlated with prostate cancer but still no one really understands why. We have already begun examining whether these pumps can explain the links between diet and prostate cancer."

"Given one in nine men in Australia may develop prostate cancer in their lifetime, this discovery could touch thousands of lives."

The publication of the study comes just in time for Movember, a month-long charity drive in which thousands of people around the globe grow moustaches to raise money for men's health issues including prostate cancer.

"This fundamental research tells us more about how prostate and other cancers grow, and will open the way for new treatments in the long term," says Movember chairman Paul Villanti.

"Movember is now one of the largest non-government global funders of prostate cancer research. We strongly support innovative targeted research that leads to significantly improved clinical tests and treatments to reduce the burden of prostate cancer. It's great to see the progress that Dr Holst and his team have made with the support of a Movember Young Investigator grant."

PCFA and Movember have been working together since 2004 to reduce the impact of prostate cancer on Australian men and their loved ones.

PCFA CEO Dr Anthony Lowe says research that has the potential to reduce the impact of prostate cancer on those who are diagnosed is a huge priority for the PCFA's grants program.

"We commend the team at the Centenary Institute on the remarkable progress they are making in this regard," Anthony Lowe says.

"This is part of a body of work that is investigating the very nature of cancer and opening up new avenues for cancer treatment," says Centenary Institute executive director Professor Mathew Vadas.


Contact: Suzie Graham
Centenary Institute

Related biology news :

1. Starving fat suppresses appetite
2. Researchers discover that same gene has opposite effects in prostate, breast cancers
3. UCLA researchers develop system that finds prostate cancer spread earlier than conventional imaging
4. Genomatix, USU and HJF execute a CRADA: Prostate cancer prognostic marker discovery by NGS
5. Cancer biomarker -- detectable by blood test -- could improve prostate cancer detection
6. USC research determines apparent genetic link to prostate cancer in African-American men
7. Mushroom compound suppresses prostate tumors
8. Microbubble-delivered combination therapy eradicates prostate cancer in vivo
9. High percentage of omega-3s in the blood may boost risk of aggressive prostate cancer
10. Jan-Åke Gustafsson leads team with $5.2M for prostate cancer research
11. No scalpel: Minimally invasive breakthrough for men’s enlarged prostates improves symptoms
Post Your Comments:
(Date:11/19/2015)... , Nov. 19, 2015  Although some 350 companies ... dominated by a few companies, according to Kalorama Information. These ... 51% of the market share of the 6.1 billion-dollar ... The World Market for Molecular Diagnostic s .    ... market is still controlled by one company and only ...
(Date:11/17/2015)... Paris , qui s,est tenu ... Paris , qui s,est tenu du 17 au ... l,innovation biométrique, a inventé le premier scanner couplé, qui ... même surface de balayage. Jusqu,ici, deux scanners étaient nécessaires, ... digitales. Désormais, un seul scanner est en mesure de ...
(Date:11/12/2015)... 2015  A golden retriever that stayed healthy despite ... has provided a new lead for treating this muscle-wasting ... Institute of MIT and Harvard and the University of ... Cell, pinpoints a protective gene that ... effects. The Boston Children,s lab of Lou Kunkel ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... TEL AVIV, Israel , Nov. 24, 2015  Tikcro Technologies Ltd. ... be held on December 29, 2015 at 11:00 a.m. Israel ... & Co., Electra Tower, 98 Yigal Allon Street, 36 th Floor, ... , election of Eric Paneth and Izhak Tamir ... and Rami Skaliter as external directors; , approval of an ...
(Date:11/24/2015)...  Twist Bioscience, a company focused on synthetic ... Bioscience chief executive officer, will present at the ... 2015 at 3:10 p.m. Eastern Time at The Lotte New ... --> --> About Twist ... on Twitter. Sign up to follow our Twitter ...
(Date:11/24/2015)... ... November 24, 2015 , ... InSphero AG, the leading supplier of ... has promoted Melanie Aregger to serve as Chief Operating Officer. , Having ... management team and was promoted to Head of InSphero Diagnostics in 2014. ...
(Date:11/24/2015)... 2015 /CNW Telbec/ - ProMetic Life Sciences Inc. (TSX: PLI) ... Pierre Laurin , President and Chief Executive Officer of ... Piper Jaffray 27 th Annual Healthcare Conference to be ... 2015. st , at 8.50am (ET) and ... the day. The presentation will be available live via a ...
Breaking Biology Technology: